Clinical trial
Correction Study of R744 in Renal Anemia Patients on Hemodialysis
NCT00433693 · Chugai Pharmaceutical, Industry · Completed
Key facts
| NCT number | NCT00433693 |
|---|---|
| Title | Correction Study of R744 in Renal Anemia Patients on Hemodialysis |
| Official title | Correction Study of Intravenous Injections of R744 to Hemodialysis Patients ( Phase Ⅲ Study ). |
| Lead sponsor | Chugai Pharmaceutical, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hemodialysis Patients |
| Intervention type | Drug |
| Interventions | R744 |
| Enrollment | 50 |
| Start date | Feb 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Feb 12, 2007 |
| Last update posted | Feb 2, 2009 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: